{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:03:03Z","timestamp":1777438983946,"version":"3.51.4"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Candida glabrata causes difficult to treat invasive candidiasis due to its antifungal resistance, mainly to azoles. The aim of the present work was to study the role of the genes ERG11, CDR1, CDR2, and SNQ2 on the resistance to voriconazole (VRC) in a set of C. glabrata strains with known in vitro and in vivo susceptibility to this drug. Eighteen clinical isolates of C. glabrata were exposed in vitro to VRC, and the expression of the cited genes was quantified by real time quantitative polymerase chain reaction (q-PCR). In addition, the ERG11 gene was amplified and sequenced to detect possible mutations. Ten synonymous mutations were found in 15 strains, two of them being reported for the first time; however, no amino acid changes were detected. ERG11 and CDR1 were the most expressed genes in all the strains tested, while the expression of CDR2 and SNQ2 was modest. Our results show that gene expression does not directly correlate with the VRC MIC. In addition, the expression profiles of ERG11 and efflux pump genes did not change consistently after exposure to VRC. Although individual analysis did not result in a clear correlation between MIC and gene expression, we did observe an increase in ERG11 and CDR1 expression in resistant strains. It is of interest that considering both in vitro and in vivo results, the slight increase in such gene expression correlates with the observed resistance to VRC.<\/jats:p>","DOI":"10.1093\/mmy\/myz014","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T20:27:41Z","timestamp":1549398461000},"page":"30-38","source":"Crossref","is-referenced-by-count":9,"title":["Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains"],"prefix":"10.1093","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-6291","authenticated-orcid":false,"given":"Patricia","family":"Navarro-Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, and Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-8906","authenticated-orcid":false,"given":"Adela","family":"Martin-Vicente","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, and Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-9301","authenticated-orcid":false,"given":"Loida","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, and Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7839-7568","authenticated-orcid":false,"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, and Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-6403","authenticated-orcid":false,"given":"Javier","family":"Capilla","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Ci\u00e8ncies de la Salut, and Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), Universitat Rovira i Virgili, Reus, Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"2020010209275387500_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.riam.2013.10.001","article-title":"Epidemiology of candidaemia and invasive candidiasis: a changing face","volume":"31","author":"Quindos","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"2020010209275387500_bib2","doi-asserted-by":"crossref","first-page":"fov114","DOI":"10.1093\/femsyr\/fov114","article-title":"Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance","volume":"16","author":"Angoulvant","year":"2015","journal-title":"FEMS Yeast Res"},{"key":"2020010209275387500_bib3","doi-asserted-by":"crossref","first-page":"87 e81\u201387","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020010209275387500_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","article-title":"Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options","volume":"62","author":"Sardi","year":"2013","journal-title":"J Med Microbiol"},{"key":"2020010209275387500_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020010209275387500_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13693780802291445","article-title":"The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study","volume":"47","author":"Kim","year":"2009","journal-title":"Med Mycol"},{"key":"2020010209275387500_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsyr\/fov025","article-title":"Tipping the balance both ways: drug resistance and virulence in Candida glabrata","volume":"15","author":"Vale-Silva","year":"2015","journal-title":"FEMS Yeast Res"},{"key":"2020010209275387500_bib8","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2020010209275387500_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ja.2015.29","article-title":"Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010\u20132012)","volume":"68","author":"Pfaller","year":"2015","journal-title":"J Antibiot (Tokyo)"},{"key":"2020010209275387500_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance","volume":"5","author":"Prasad","year":"2014","journal-title":"Front Pharmacol"},{"key":"2020010209275387500_bib11","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","article-title":"Resistance of Candida species to fluconazole","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","article-title":"Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance","volume":"49","author":"Sanguinetti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1128\/AAC.45.4.1174-1183.2001","article-title":"Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata","volume":"45","author":"Sanglard","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib15","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020010209275387500_bib16","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/EC.00073-10","article-title":"Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon","volume":"10","author":"Caudle","year":"2011","journal-title":"Eukaryot Cell"},{"key":"2020010209275387500_bib18","doi-asserted-by":"crossref","first-page":"e01070","DOI":"10.1128\/AAC.01070-18","article-title":"Relative contribution of the ABC transporters Cdr1, Pdh1, and Snq2 to azole resistance in Candida glabrata","volume":"62","author":"Whaley","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot Cell"},{"key":"2020010209275387500_bib20","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/AAC.43.11.2798","article-title":"Overexpression of Erg11p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae","volume":"43","author":"Kontoyiannis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib21","first-page":"1","article-title":"Overexpression of both ERG11 and ABC2 genes might be responsible for itraconazole resistance in clinical isolates of Candida krusei","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"2020010209275387500_bib22","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/AAC.00123-14","article-title":"Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment","volume":"58","author":"Lackner","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jgar.2016.03.003","article-title":"Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling","volume":"5","author":"Nabili","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"2020010209275387500_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/0074-02760150400","article-title":"Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species","volume":"111","author":"Silva","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2020010209275387500_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijantimicag.2015.12.020","article-title":"Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata","volume":"47","author":"Sanchis","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2020010209275387500_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2199-13-22","article-title":"Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment","volume":"13","author":"Li","year":"2012","journal-title":"BMC Mol Biol"},{"key":"2020010209275387500_bib27","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1128\/AAC.00555-13","article-title":"Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals","volume":"57","author":"Eddouzi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib28","author":"CLSI","year":"2016","journal-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard\u2014Fourth Edition"},{"key":"2020010209275387500_bib29","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement","author":"CLSI","year":"2012"},{"key":"2020010209275387500_bib30","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/JCM.03044-13","article-title":"Impact of new antifungal breakpoints on antifungal resistance in Candida species","volume":"52","author":"Fothergill","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2020010209275387500_bib31","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1128\/AAC.02615-13","article-title":"Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole","volume":"58","author":"Espinel-Ingroff","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/JCM.36.6.1625-1629.1998","article-title":"Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption","volume":"36","author":"Muller","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2020010209275387500_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on","volume":"1","author":"Chomczynski","year":"2006","journal-title":"Nat Protoc"},{"key":"2020010209275387500_bib34","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1128\/AAC.06253-11","article-title":"Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B","volume":"56","author":"Hull","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib35","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"2020010209275387500_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"408","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2020010209275387500_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10096-013-2009-3","article-title":"Candida glabrata: a review of its features and resistance","volume":"33","author":"Rodrigues","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020010209275387500_bib38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","article-title":"A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients","volume":"7","author":"Rajendran","year":"2016","journal-title":"Front Microbiol"},{"key":"2020010209275387500_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2020010209275387500_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2020010209275387500_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12281-014-0210-1","article-title":"Multidrug- and cross-resistant Candida: The looming threat","volume":"9","author":"Lackner","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"2020010209275387500_bib42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00284-016-1039-3","article-title":"Principles of a new protocol for prediction of azole resistance in Candida albicans Iifections on the basis of ERG11 polymorphisms","volume":"73","author":"Caban","year":"2016","journal-title":"Curr Microbiol"},{"key":"2020010209275387500_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11046-014-9831-8","article-title":"The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia","volume":"179","author":"Tan","year":"2015","journal-title":"Mycopathologia"},{"key":"2020010209275387500_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"2020010209275387500_bib45","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.44.5.1740-1743.2006","article-title":"Clinical significance of azole antifungal drug cross-resistance in Candida glabrata","volume":"44","author":"Panackal","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2020010209275387500_bib46","first-page":"458","article-title":"Expression of efflux pumps and fatty acid activator one genes in azole resistant Candida glabrata isolated from immunocompromised patients","volume":"54","author":"Farahyar","year":"2016","journal-title":"Acta Med Iran"},{"key":"2020010209275387500_bib47","doi-asserted-by":"crossref","first-page":"e0180990","DOI":"10.1371\/journal.pone.0180990","article-title":"Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species","volume":"12","author":"Nagayoshi","year":"2017","journal-title":"PLoS One"},{"key":"2020010209275387500_bib48","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1128\/AAC.03921-14","article-title":"Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and rho0 cells","volume":"58","author":"Paul","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib49","doi-asserted-by":"crossref","first-page":"e1000268","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PLoS Pathog"},{"key":"2020010209275387500_bib50","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/AAC.00535-10","article-title":"Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates","volume":"54","author":"Tsai","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2008.06.093","article-title":"RTA2, a novel gene involved in azole resistance in Candida albicans","volume":"373","author":"Jia","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"2020010209275387500_bib52","doi-asserted-by":"crossref","first-page":"6060\u20136066","DOI":"10.1128\/AAC.00732-16","article-title":"The RTA3 gene, encoding a putative lipid translocase, influences the susceptibility of Candida albicans to fluconazole","volume":"60","author":"Whaley","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib53","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01271-10","article-title":"Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice","volume":"55","author":"Ferrari","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020010209275387500_bib54","doi-asserted-by":"crossref","first-page":"fov027","DOI":"10.1093\/femsyr\/fov027","article-title":"System-level impact of mitochondria on fungal virulence: to metabolism and beyond","volume":"15","author":"Calderone","year":"2015","journal-title":"FEMS Yeast Res"},{"key":"2020010209275387500_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/21505594.2017.1414133","article-title":"Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi","volume":"9","author":"Verma","year":"2018","journal-title":"Virulence"},{"key":"2020010209275387500_bib56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1099\/jmm.0.000062","article-title":"Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland","volume":"64","author":"Szweda","year":"2015","journal-title":"J Med Microbiol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/1\/30\/31677503\/myz014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/58\/1\/30\/31677503\/myz014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T18:29:33Z","timestamp":1606415373000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/58\/1\/30\/5370455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,6]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz014","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,3,6]]}}}